DANTE DURAND: Open Payments
NPI 1093754335 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,827 in 24 payments from 4 companies in 2025. Trend: 2023 $8,117 · 2024 $4,166 · 2025 $6,827
Speaker / faculty: $4,271Travel & lodging: $1,559Food & beverage: $997
| Company | Payments | Amount |
|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 7 | $4,524 |
| Neurocrine BioSciences, Inc. | 13 | $2,075 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $209 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
Products named: CAPLYTA, REJOYN, UZEDY.
Industry payments across FL — which companies pay providers there.
